When they conducted genetic knockdown of HSD3B1 or applied pharmacologic inhibition of 3βHSD1 with trilostane, they observed attenuation of cellular proliferation and migration of breast cancer cell lines. The gene discussed is HSD3B1; the disease is breast cancer.